Brokerages Set ArriVent BioPharma, Inc. (NASDAQ:AVBP) PT at $39.29
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) has received a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price […]
ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) has received a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price […]
